These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immuno-oncologic signature of malignant transformation in oral squamous cell carcinoma. Elnaggar M; Chaisuparat R; Ghita I; Bentzen SM; Dyalram D; Ord RA; Lubek JE; Younis RH Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Nov; 136(5):612-622. PubMed ID: 37739913 [TBL] [Abstract][Full Text] [Related]
6. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma. Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754 [TBL] [Abstract][Full Text] [Related]
7. A reverse Warburg metabolism in oral squamous cell carcinoma is not dependent upon myofibroblasts. Jensen DH; Therkildsen MH; Dabelsteen E J Oral Pathol Med; 2015 Oct; 44(9):714-21. PubMed ID: 25420473 [TBL] [Abstract][Full Text] [Related]
8. Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation? Coletta RD; Salo T Oral Dis; 2018 Mar; 24(1-2):84-88. PubMed ID: 29480603 [TBL] [Abstract][Full Text] [Related]
9. 4-nitroquinoline 1-oxide induces immune cells death to onset early immunosuppression during oral squamous cell carcinoma development. Sahu SR; Thakur S; Peroumal D; Utkalaja BG; Dutta A; Kumari P; Subhadarsini I; Acharya N Front Immunol; 2023; 14():1274519. PubMed ID: 37936711 [TBL] [Abstract][Full Text] [Related]
10. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma. Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W Oncology; 2018; 95(5):297-308. PubMed ID: 30134247 [TBL] [Abstract][Full Text] [Related]
11. Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma. de-Assis EM; Pimenta LG; Costa-e-Silva E; Souza PE; Horta MC Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e733-8. PubMed ID: 22322518 [TBL] [Abstract][Full Text] [Related]
12. Dynamics of regulatory T cells (T Aggarwal S; Sharma SC; N Das S J Surg Oncol; 2017 Dec; 116(8):1103-1113. PubMed ID: 28833201 [TBL] [Abstract][Full Text] [Related]
13. Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy. Lee YM; Hsu CL; Chen YH; Ou DL; Hsu C; Tan CT Cancer Immunol Res; 2023 Nov; 11(11):1553-1567. PubMed ID: 37669022 [TBL] [Abstract][Full Text] [Related]
14. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis. Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306 [TBL] [Abstract][Full Text] [Related]
15. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes. Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907 [TBL] [Abstract][Full Text] [Related]
16. Reduced CD8 Chaves ALF; Silva AG; Maia FM; Lopes GFM; de Paulo LFB; Muniz LV; Dos Santos HB; Soares JMA; Souza AA; de Oliveira Barbosa LA; Loyola AM; Murta EFC; Michelin MA; de Azambuja Ribeiro RIM Clin Oral Investig; 2019 Apr; 23(4):1913-1919. PubMed ID: 30229300 [TBL] [Abstract][Full Text] [Related]
17. Blockade of adenosine A2A receptor enhances CD8 Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420 [TBL] [Abstract][Full Text] [Related]